The story of Viagra offers a tangled case study for pharmaceutical backers . Initially a runaway success, producing billions in profits, the patent lapse has opened the challenges of relying on a isolated product. While generic versions have drastically eroded share, questions remain about the lo

The neon lights of Sin City have always been synonymous with risk, but lately, a new kind of gamble has taken center stage: copyright. With Bitcoin and Ethereum prices soaring to dizzying heights, a wave of investors are flocking to the desert metropolis, hoping to get lucky. Fueling this frenzy